20512 results for «»

Filter By

20512 results

Juan Manuel Monteagudo Ruiz

Madrid, Spain

Adam Groothuis

Nathan Bunt

Ali Kerem Yılmaz

Istanbul, Türkiye

Ali Kerem Yılmaz

Robert Burke

Scottsdale, United States of America

Pretreatment with P2Y12 inhibitors in ST-segment elevation myocardial infarction - insights from the Bern-PCI Registry

26 Jan 2024

This study sought to compare outcomes between patients presenting with STEMI before and after the recent ESC guidelines for the management of ACS recommend against pre-treatment with P2Y12 inhibitors in STEMI patients.

Reviewer

Leonidas Koliastasis
Panagiotis Xaplanteris

Reviewer

Panagiotis Xaplanteris
Pretreatment with P2Y12 inhibitors in ST-segment elevation myocardial infarction - insights from the Bern-PCI Registry

Empowering European Healthcare Systems: RESIL-Card, an EU4Health Project, Launches to Enhance Cardiovascular Care Resilience

19 Jan 2024

Paris, 18 January 2024: The consortium and supporting partners that make up the RESIL-Card project kick-started the venture on 1st December 2023.
The 3-year project received a funding grant from the European Commission under the EU4Health Work Programme to strengthen European healthcare systems in providing continuity of care for...

RESIL-Card_Image_project concept

Sumie Takao

Fukuoka, Japan

Yasuhiro Tanaka

Tokyo, Japan

Coronary physiology guidance vs conventional angiography for optimization of percutaneous coronary intervention: the AQVA-II Trial

24 Jan 2024

The primary aim of this study was to demonstrate the superiority of physiology-guided PCI, using either angiography or microcatheter-derived FFR, over conventional angiography-based PCI in complex high-risk indicated procedures (CHIPs) in obtaining a higher FFR post-PCI.

Reviewer

Salvatore Brugaletta
Coronary physiology guidance vs conventional angiography for optimization of percutaneous coronary intervention: the AQVA-II Trial

Tatsuo Takahashi

Tokyo, Japan

Unraveling aortic valve complexities: grading challenges, intervention decisions, and advanced imaging techniques

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

Explore the complexities of aortic valve disorders in this PCR Imaging Valves Madrid 2024 session, covering topics from grading challenges to intervention decisions in both asymptomatic and symptomatic patients, and learn more about advanced imaging techniques for quantifying aortic regurgitation severity and navigating treatment choices for...

Unraveling aortic valve complexities: grading challenges, intervention decisions, and advanced imaging techniques

Comprehensive assessment of mitral valve disorders and treatment outcomes

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

This session offers a comprehensive exploration of mitral valve disorders, covering diagnosis and severity assessment from multiple perspectives. From morphology-based diagnosis to echocardiography and CMR assessments, gain insights into distinguishing between rheumatic and calcific mitral stenosis, evaluating outcomes post-TMVR and surgical repair, and assessing bioprosthetic and...

Comprehensive assessment of mitral valve disorders and treatment outcomes

Minimal-metal PCI: a drug-coated balloon philosophy combined with selective lesion stenting where necessary - the hybrid approach

13 Mar 2024

Watch the replay of this webinar with P. O'Kane, D. Pan and H. Routledge to understand what factors during PCI lead to the switch from DCB to DES and much more!

Minimal-metal PCI

Rapid-fire - Vascular access in TAVI

17 Feb 2024 – From PCR Tokyo Valves 2024

Discover a selection of rapid-fire TAVI vascular access cases: how to deliver a transcatheter heart valve in a calcified aorta, using the buddy wire technique in TAVR with severely tortuous aorta, and more!

First Patient enrolled in the clinical study of Bentley’s BeGraft and Cook’s Zenith® Fenestrated+ Endovascular Graft

09 Feb 2024

Chip Hance

Lake Bluff, United States of America

TAVI for patients with concomitant coronary artery disease - LIVE case

17 Feb 2024 – From PCR Tokyo Valves 2024

An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...

TAVI for patients with concomitant coronary artery disease - LIVE case

Laura Minarsch

Laguna Beach, United States of America

The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management

17 Feb 2024 – From PCR Tokyo Valves 2024

This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...

The optimal first valve
Didn’t find what you were looking for?